Mesoblast Limited

MESONASDAQHealthcare● Active

$13.90

$-0.05(-0.36%)

Market Cap$1.8B

P/E Ratio—

52W High$21.5

52W Low$9.88

Avg Volume224K

Open$14.11

Beta0.79

Overview

Mesoblast Limited (MESO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · MESO · as of Aug 29, 2025

Latest filing snapshot

+8+10.96%vs prior year

Mesoblast Limited (MESO) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-06-30·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+10.96%

Revenue / Employee

$212.3K

Net Income / Employee

$-1.26M

Market Cap

$1.8B

MESO Employee Count

2016 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2025-08-29	2025-06-30	81	+8	+10.96%
2024-08-29	2024-06-30	73	-10	-12.05%
2023-08-31	2023-06-30	83	+6	+7.79%
2022-08-31	2022-06-30	77	-6	-7.23%
2021-08-31	2021-06-30	83	-19	-18.63%
2020-09-03	2020-06-30	102	+19	+22.89%
2019-09-09	2019-06-30	83	+2	+2.47%
2018-08-31	2018-06-30	81	+6	+8.00%
2017-08-30	2017-06-30	75	-33	-30.56%
2016-08-25	2016-06-30	108	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Cogent Biosciences, Inc.

Structure Therapeutics Inc.

163$2.1B #6

EWTX

Edgewise Therapeutics, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · MESO peer comparison

About MESO employees

MESO Employees · Headcount

Mesoblast Limited (MESO) employee data is sourced from the annual SEC 20-F filing. As of 2025, Mesoblast Limited had 81 full-time employees globally. Full-time employees only. Global consolidated headcount.

Mesoblast Limited employs 81 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $212,321, reflecting the company's operational efficiency.

Mesoblast Limited's workforce increased by 8 (10.96%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Mesoblast Limited's revenue per employee of $212,321 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

MESO Employees · 5 questions

As of the latest SEC 20-F filing (2025), Mesoblast Limited had 81 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Mesoblast Limited employee counthow many employees does Mesoblast Limited haveMESO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-08-29